1. Home
  2. CRGX vs ESCA Comparison

CRGX vs ESCA Comparison

Compare CRGX & ESCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRGX
  • ESCA
  • Stock Information
  • Founded
  • CRGX 2021
  • ESCA 1922
  • Country
  • CRGX United States
  • ESCA United States
  • Employees
  • CRGX N/A
  • ESCA N/A
  • Industry
  • CRGX
  • ESCA Recreational Games/Products/Toys
  • Sector
  • CRGX
  • ESCA Consumer Discretionary
  • Exchange
  • CRGX Nasdaq
  • ESCA Nasdaq
  • Market Cap
  • CRGX 190.0M
  • ESCA 209.5M
  • IPO Year
  • CRGX 2023
  • ESCA N/A
  • Fundamental
  • Price
  • CRGX $4.27
  • ESCA $13.90
  • Analyst Decision
  • CRGX Hold
  • ESCA
  • Analyst Count
  • CRGX 7
  • ESCA 0
  • Target Price
  • CRGX $4.67
  • ESCA N/A
  • AVG Volume (30 Days)
  • CRGX 647.1K
  • ESCA 16.8K
  • Earning Date
  • CRGX 08-11-2025
  • ESCA 07-24-2025
  • Dividend Yield
  • CRGX N/A
  • ESCA 4.44%
  • EPS Growth
  • CRGX N/A
  • ESCA 9.37
  • EPS
  • CRGX N/A
  • ESCA 0.99
  • Revenue
  • CRGX N/A
  • ESCA $249,685,000.00
  • Revenue This Year
  • CRGX $58.18
  • ESCA N/A
  • Revenue Next Year
  • CRGX N/A
  • ESCA N/A
  • P/E Ratio
  • CRGX N/A
  • ESCA $13.95
  • Revenue Growth
  • CRGX N/A
  • ESCA N/A
  • 52 Week Low
  • CRGX $3.00
  • ESCA $12.53
  • 52 Week High
  • CRGX $25.45
  • ESCA $16.99
  • Technical
  • Relative Strength Index (RSI)
  • CRGX 45.02
  • ESCA 43.01
  • Support Level
  • CRGX $4.33
  • ESCA $13.33
  • Resistance Level
  • CRGX $4.48
  • ESCA $14.46
  • Average True Range (ATR)
  • CRGX 0.19
  • ESCA 0.50
  • MACD
  • CRGX -0.02
  • ESCA -0.08
  • Stochastic Oscillator
  • CRGX 21.14
  • ESCA 27.40

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.

About ESCA Escalade Incorporated

Escalade Inc manufactures and distributes sporting goods for a varied range of activities. These sports include archery, table tennis, basketball goals, trampoline, play systems, fitness, game tables like hockey and soccer, billiards, darting, and other outdoor games. These products are sold under the brand names like Goalrilla, Goalsetter, Woodplay, Silverback, Nodor, Rage, Child Life, among others. The geographic segments in which the company operates are North America, Europe and others out of which a substantial part of the revenue is generated from North America region.

Share on Social Networks: